Newsletter | April 12, 2025

04.12.25 -- Bioprocess Online Best Of March

MARCH'S BEST FEATURED EDITORIAL

ADC Manufacturing's Biggest CMC Challenges And Ways To Approach Them

Manufacturing ADCs is inherently more complex than other biologic drug products. Let's explore some of the key issues, including aggregation, solubility, and thermal instability.

Comparison Of Sterilization Methods: Vaporized Vs. Aerosolized H2O2

Hydrogen peroxide (H2O2) is one of the most frequently used chemical compounds for sterilization. This article compares the benefits and trade-offs of using the vapor form vs. aerosol form.

New Reference Standards To Support Quality of AAV Raw Materials

The United States Pharmacopeia aims to help gene therapy manufacturers address the challenges that come with complex starting materials like endonuclease and plasmids.

MARCH'S BEST INDUSTRY INSIGHTS

The Power Of The Pool: Using Bulk Cultures For Clinical Trial Manufacturing

Stable bulk cultures, made highly uniform using transposase-mediated technologies, may be the key to expediting clone selection for many biopharmaceutical applications.

Tech Transfer: 7 Unique Challenges For Advanced Therapeutics

Ensure the success of your tech transfer by addressing these key challenges and optimizing your processes for seamless scalability and compliance.

New Innovations In Cell Line Development

Learn how you can overcome the challenges of cell line development including stable transfection, data management, media development, screening and monoclonality verification, and scale up.

MARCH'S BEST SOLUTIONS

Monitor And Control Both Glucose And Lactate In Real-Time

Techfors-S Pilot Bioreactor

GS Effex® Cell Line For Enhanced Antibody Effector Function

Connect With Bioprocess Online: